Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
10
Bearish filings
175
Named actors
28
Disclosed $ (bull / bear)
$224.6M + 1 of unknown size / $1.6B + 5 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-01 | Director Epperly Melissa B, | sold | $608K | SEC ↗ |
| 2026-10-01 | Director Epperly Melissa B, | sold | $33K | SEC ↗ |
| 2026-09-30 | President & Immunovant CEO Venker Eric | sold | $7.3M | SEC ↗ |
| 2026-09-30 | Officer (via Rockefeller Financial LLC) Venker Eric | filed notice to sell | $7.3M | SEC ↗ |
| 2026-09-15 | Director Fitzgerald Meghan | sold | $16K | SEC ↗ |
160 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-15 | Director Fitzgerald Meghan | sold | $187K | SEC ↗ |
| 2026-09-15 | Director Epperly Melissa B, | sold | $172K | SEC ↗ |
| 2026-09-15 | Director Epperly Melissa B, | sold | $24K | SEC ↗ |
| 2026-09-15 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MEGHAN FITZGERALD | filed notice to sell | $210K | SEC ↗ |
| 2026-09-15 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MELISSA EPPERLY | filed notice to sell | $931K | SEC ↗ |
| 2026-09-08 | Director Fitzgerald Meghan | sold | $798K | SEC ↗ |
| 2026-09-08 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MEGHAN FITZGERALD | filed notice to sell | $699K | SEC ↗ |
| 2026-08-28 | President & Immunovant CEO Venker Eric | sold | $5.9M | SEC ↗ |
| 2026-08-28 | President & Immunovant CEO Venker Eric | sold | $1.2M | SEC ↗ |
| 2026-08-28 | Officer (via Rockefeller Financial LLC) Venker Eric | filed notice to sell | $7.1M | SEC ↗ |
| 2026-08-21 | President & CIO Sukhatme Mayukh | sold | $5.3M | SEC ↗ |
| 2026-08-21 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MAYUKH SUKHATME | filed notice to sell | $5.3M | SEC ↗ |
| 2026-08-20 | President & CIO Sukhatme Mayukh | sold | $653K | SEC ↗ |
| 2026-08-20 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MAYUKH SUKHATME | filed notice to sell | $653K | SEC ↗ |
| 2026-08-19 | President & CIO Sukhatme Mayukh | sold | $6.4M | SEC ↗ |
| 2026-08-19 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MAYUKH SUKHATME | filed notice to sell | $6.4M | SEC ↗ |
| 2026-08-18 | President & CIO Sukhatme Mayukh | sold | $3.8M | SEC ↗ |
| 2026-08-18 | President & CIO Sukhatme Mayukh | sold | $1.2M | SEC ↗ |
| 2026-08-18 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MAYUKH SUKHATME | filed notice to sell | $5.0M | SEC ↗ |
| 2026-08-17 | President & CIO Sukhatme Mayukh | sold | $10.3M | SEC ↗ |